These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 7507540)

  • 21. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antihypertensive therapy on hypertensive heart disease.
    Messerli FH; Kaesser UR; Losem CJ
    Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of left ventricular hypertrophy and implications for regression.
    Artham SM; Lavie CJ; Milani RV; Patel DA; Verma A; Ventura HO
    Prog Cardiovasc Dis; 2009; 52(2):153-67. PubMed ID: 19732607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertension, left ventricular hypertrophy and heart failure].
    Mancia G; Giannattasio C; Grassi G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():5S-8S. PubMed ID: 8117522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease.
    Devereux RB; Roman MJ
    J Hypertens Suppl; 1993 Jun; 11(4):S3-9. PubMed ID: 8377033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations in treating hypertension: focus on risk factors.
    Messerli FH
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():3-6. PubMed ID: 2151045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concept of cardioreparation: Part 2. Medical implications of cardioreparation.
    Cleland JG; Dewhurst NG; Murphy RL; Struijker Boudier HA; Tan LB; Visser CA
    J Cardiovasc Risk; 1996 Jun; 3(3):287-93. PubMed ID: 8863101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.
    Mansoor GA; Massie BM
    Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
    J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
    Agabiti-Rosei E
    Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension and the heart].
    Wachtell K; Andersen NH; Svendsen TL
    Ugeskr Laeger; 2009 Jun; 171(25):2113-6. PubMed ID: 19671394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression of left ventricular hypertrophy: do antihypertensive classes differ?
    Sheridan DJ
    J Hypertens Suppl; 2000 Jul; 18(3):S21-7. PubMed ID: 10952084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension and heart disease].
    Gerdts E; Omvik P; Mo R; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):802-5. PubMed ID: 15039815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.